Desmopressin for risperidone-induced enuresis.
Bennett
J A
JA
University of Cincinnati College of Pharmacy, University of Cincinnati Medical Center, Ohio 45267-0004.
Keck
P E
PE
Wallhausser
L J
LJ
D000281:Administration, Intranasal; D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003894:Deamino Arginine Vasopressin / Q000627:therapeutic use*; D004311:Double-Blind Method; D004775:Enuresis / Q000139:chemically induced* / Q000188:drug therapy; D005260:Female; D006220:Haloperidol / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007555:Isoxazoles / Q000009:adverse effects* / Q000627:therapeutic use; D010880:Piperidines / Q000009:adverse effects* / Q000627:therapeutic use; D018967:Risperidone; D012559:Schizophrenia / Q000188:drug therapy*; D012565:Schizophrenic Psychology
D014150:Antipsychotic Agents; D007555:Isoxazoles; D010880:Piperidines; D003894:Deamino Arginine Vasopressin; D006220:Haloperidol; D018967:Risperidone